Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,162Revenue $M581Net Margin (%)58.0Z-Score4.4
Enterprise Value $M1,370EPS $1.9Operating Margin %92.5F-Score3
P/E(ttm))3.7Cash Flow Per Share $1.5Pre-tax Margin (%)89.9Higher ROA y-yN
Price/Book2.810-y EBITDA Growth Rate %0Quick Ratio1.3Cash flow > EarningsN
Price/Sales2.15-y EBITDA Growth Rate %12.8Current Ratio1.3Lower Leverage y-yY
Price/Cash Flow5.0y-y EBITDA Growth Rate %21.7ROA % (ttm)44.1Higher Current Ratio y-yN
Dividend Yield %8.4Insider Buy (3m)1ROE % (ttm)154Less Shares Outstanding y-yN
Payout Ratio %32.0Shares Outstanding M161ROI % (ttm)162Gross Margin Increase y-yN

Gurus Latest Trades with PDLI

Number of guru portfolios checked: 85. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
PDLIJoel Greenblatt 2014-12-31 Add0.01%$7.325 - $8.53
($7.92)
$ 7.02-11%Add 603.94%183,003
PDLIJoel Greenblatt 2014-09-30 Reduce-0.09%$7.51 - $10.26
($9.3)
$ 7.02-24%Reduce -96.71%25,997
PDLIJohn Hussman 2014-06-30 Sold Out -0.68%$8 - $9.85
($8.9)
$ 7.02-21%Sold Out0
PDLIJoel Greenblatt 2014-06-30 Reduce-0.11%$8 - $9.85
($8.9)
$ 7.02-21%Reduce -52.58%789,804
PDLIJoel Greenblatt 2014-03-31 Reduce-0.34%$7.46 - $9.14
($8.57)
$ 7.02-18%Reduce -50.19%1,665,543
PDLIJohn Hussman 2013-12-31 Reduce-0.49%$7.59 - $10.1
($8.43)
$ 7.02-17%Reduce -50.99%1,087,000
PDLIJoel Greenblatt 2013-09-30 Add0.15%$7.72 - $8.44
($8.04)
$ 7.02-13%Add 24.84%2,890,564
PDLIJohn Hussman 2013-09-30 Reduce-0.21%$7.72 - $8.44
($8.04)
$ 7.02-13%Reduce -21.04%2,218,000
PDLIJoel Greenblatt 2013-03-31 Add0.15%$6.65 - $7.53
($7.08)
$ 7.02-1%Add 23.5%2,135,460
PDLIJoel Greenblatt 2012-12-31 Add0.59%$7.09 - $8.37
($7.75)
$ 7.02-9%Add 561.89%1,729,133
PDLIJohn Hussman 2012-12-31 Add0.09%$7.09 - $8.37
($7.75)
$ 7.02-9%Add 20.19%3,012,000
PDLIJohn Hussman 2012-09-30 Add0.29%$6.59 - $7.73
($7.11)
$ 7.02-1%Add 176.91%2,506,000
PDLIJoel Greenblatt 2012-03-31 Add0.04%$6.02 - $6.58
($5.93)
$ 7.0218%Add 33.54%270,346
PDLISeth Klarman 2012-03-31 Sold Out -1.5%$6.02 - $6.58
($5.93)
$ 7.0218%Sold Out0
PDLIJoel Greenblatt 2011-12-31 Add0.04%$5.35 - $6.4
($5.97)
$ 7.0218%Add 31.29%202,444
PDLISeth Klarman 2011-12-31 Reduce-1.4%$5.35 - $6.4
($5.97)
$ 7.0218%Reduce -48.84%8,000,000
PDLIGeorge Soros 2011-12-31 Sold Out -0.001%$5.35 - $6.4
($5.97)
$ 7.0218%Sold Out0
PDLISeth Klarman 2011-09-30 Add1.17%$5.47 - $6.39
($5.91)
$ 7.0219%Add 68.81%15,636,000
PDLIJohn Hussman 2011-09-30 Buy 0.08%$5.47 - $6.39
($5.91)
$ 7.0219%New holding, 905000 sh.905,000
PDLIJoel Greenblatt 2011-09-30 Add0.04%$5.47 - $6.39
($5.91)
$ 7.0219%Add 41.81%154,201
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

PDLI is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
PDLI Joel Greenblatt 2014-12-31183,0030.110.01+603.94%
PDLI Jean-Marie Eveillard 2014-12-312,80000
Premium Most recent portfolio changes are included for Premium Members only!


PDLI: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
SELICK HAROLD EDirector 2014-11-26Buy6,000$8.08-13.12view
Lindell Jody SDirector 2011-03-15Buy374$5.3331.71view
LARSON CHRISTINE RVice President and CFO 2010-05-14Buy5,000$5.7122.94view
LARSON CHRISTINE RVice President and CFO 2010-04-30Buy10,000$6.1813.59view
KLEIN JOSEPH IIIDirector 2009-11-04Sell24,000$8.33-15.73view
Lindell Jody SDirector 2009-06-15Buy3,000$7.76-9.54view
SANDMAN PAUL WDirector 2009-04-08Buy10,000$7.38-4.88view
SANDMAN PAUL WDirector 2009-04-08Buy10,000$7.38-4.88view
KLEIN JOSEPH IIIDirector 2008-05-20Buy500$9.5-26.11view
KLEIN JOSEPH IIIDirector 2008-05-06Buy500$9.6-26.88view

Press Releases about PDLI :

    Quarterly/Annual Reports about PDLI:

    News about PDLI:

    Articles On GuruFocus.com
    SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against PDL BioPharma, Oct 17 2014 
    SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against PDL BioPharma Inc Oct 15 2014 
    Hot Picks with High Yields Jul 23 2013 
    My 3 Favorite Healthcare Dividend Stocks with Highest Float Short Ratio Jun 03 2013 
    comment on PDLI May 12 2013 
    My 4 Favorites From The 20 Cheapest Healthcare Dividend Stock List May 02 2013 
    FV 22 MSN 10 Apr 19 2013 
    68 Top-Yielding Stocks with Ex-Dividend Date in March 2013 Feb 27 2013 
    20 Best Yielding Healthcare Growth Stocks and Which to Buy Feb 02 2013 
    comment on PDLI Nov 13 2012 

    More From Other Websites
    PDL BioPharma Announces Dismissal of Third and Final Shareholder Lawsuit Mar 03 2015
    PDL BioPharma Announces Dismissal of Third and Final Shareholder Lawsuit Mar 03 2015
    PDL BioPharma Announces Fourth Quarter and Full Year 2014 Financial Results Mar 03 2015
    PDL BioPharma to Hold Annual Meeting of Stockholders on May 28, 2015 Mar 03 2015
    PDL BioPharma to Hold Annual Meeting of Stockholders on May 28, 2015 Feb 26 2015
    10-K for PDL BioPharma, Inc. Feb 25 2015
    PDL BIOPHARMA, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits Feb 25 2015
    What We're Trading Feb 24 2015
    PDL BioPharma Inc Earnings Call scheduled for 4:30 pm ET today Feb 23 2015
    PDL BIOPHARMA, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD... Feb 23 2015
    PDL BioPharma Announces Fourth Quarter and Full Year 2014 Financial Results Feb 23 2015
    Q4 2014 PDL BioPharma Inc Earnings Release - After Market Close Feb 23 2015
    PDL BioPharma to Announce Fourth Quarter and Full Year 2014 Financial Results on February 23, 2015 Feb 17 2015
    PDL BioPharma to Announce Fourth Quarter and Full Year 2014 Financial Results on February 23, 2015 Feb 17 2015
    PDL BIOPHARMA, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits Feb 09 2015
    PDL BioPharma to Present at Upcoming Investor Conferences Feb 04 2015
    PDL BIOPHARMA, INC. Files SEC form 8-K, Change in Directors or Principal Officers Jan 30 2015
    PDL BioPharma Announces 2015 Regular Quarterly Dividends Jan 29 2015
    PDL BIOPHARMA, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits Jan 29 2015
    PDL BioPharma Announces 2015 Regular Quarterly Dividends Jan 29 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK